chr2-190880872-C-CGCAGCAGCAGCAGCA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_014905.5(GLS):c.-179_-165dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0057 ( 6 hom., cov: 0)
Exomes 𝑓: 0.0083 ( 628 hom. )
Failed GnomAD Quality Control
Consequence
GLS
NM_014905.5 5_prime_UTR
NM_014905.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.922
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-190880872-C-CGCAGCAGCAGCAGCA is Benign according to our data. Variant chr2-190880872-C-CGCAGCAGCAGCAGCA is described in ClinVar as [Benign]. Clinvar id is 1879513.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00568 (850/149608) while in subpopulation AMR AF= 0.0108 (163/15112). AF 95% confidence interval is 0.00943. There are 6 homozygotes in gnomad4. There are 430 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLS | NM_014905.5 | c.-179_-165dup | 5_prime_UTR_variant | 1/18 | ENST00000320717.8 | ||
LOC124906110 | XR_007087791.1 | n.772_773insTGCTGCTGCTGCTGC | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLS | ENST00000320717.8 | c.-179_-165dup | 5_prime_UTR_variant | 1/18 | 1 | NM_014905.5 | P1 | ||
GLS | ENST00000338435.9 | c.-179_-165dup | 5_prime_UTR_variant | 1/15 | 1 | ||||
ENST00000413911.1 | n.843_844insTGCTGCTGCTGCTGC | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
GLS | ENST00000479552.1 | n.35_49dup | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00567 AC: 848AN: 149508Hom.: 6 Cov.: 0
GnomAD3 genomes
AF:
AC:
848
AN:
149508
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00833 AC: 4945AN: 593342Hom.: 628 Cov.: 0 AF XY: 0.00808 AC XY: 2554AN XY: 316130
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4945
AN:
593342
Hom.:
Cov.:
0
AF XY:
AC XY:
2554
AN XY:
316130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00568 AC: 850AN: 149608Hom.: 6 Cov.: 0 AF XY: 0.00590 AC XY: 430AN XY: 72928
GnomAD4 genome
AF:
AC:
850
AN:
149608
Hom.:
Cov.:
0
AF XY:
AC XY:
430
AN XY:
72928
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
GLS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 29, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | GLS: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at